SLEEP LAB: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SLEEP LAB
Largest movements
- Stocks and contracts -€21,205
down €21,205 (-27.5%), from €77,219 to €56,014
- Receivables within one year -€20,076
down €20,076 (-43.1%), from €46,571 to €26,495
of which Trade receivables: -€24,215
- Cash +€8,022
up €8,022 (+44.1%), from €18,180 to €26,202
mainly Stocks and contracts (+€21,205) and Receivables within one year (+€20,076)
- Debts after one year -€16,878
down €16,878 (-36.5%), from €46,265 to €29,386
- Trade debts -€12,488
down €12,488 (-35.5%), from €35,137 to €22,649
- Tax, wage and social debts -€9,050
down €9,050 (-85.5%), from €10,583 to €1,533
- Reserves +€5,158
up €5,158 (+11.5%), from €44,986 to €50,143
- Gross operating margin -€39,517
down €39,517 (-86.6%), from €45,607 to €6,090
- Taxes -€8,497
down €8,497 (-80.3%), from €10,583 to €2,086
- Financial income -€1,756
down €1,756 (-43.1%), from €4,078 to €2,322
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €141,970 | €108,711 | -€33,259 | -23.4% |
| Current assets | 29/58 | €141,970 | €108,711 | -€33,259 | -23.4% |
| Stocks and contracts in progress | 3 | €77,219 | €56,014 | -€21,205 | -27.5% |
| Stocks | 30/36 | €77,219 | €56,014 | -€21,205 | -27.5% |
| Amounts receivable within one year | 40/41 | €46,571 | €26,495 | -€20,076 | -43.1% |
| Trade receivables | 40 | €45,796 | €21,580 | -€24,215 | -52.9% |
| Other amounts receivable | 41 | €776 | €4,914 | +€4,139 | +533.7% |
| Cash at bank and in hand | 54/58 | €18,180 | €26,202 | +€8,022 | +44.1% |
| Deferred charges and accrued income | 490/1 | €0 | - | = | |
| Total equity and liabilities | 10/49 | €141,970 | €108,711 | -€33,259 | -23.4% |
| Equity | 10/15 | €49,986 | €55,143 | +€5,158 | +10.3% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €44,986 | €50,143 | +€5,158 | +11.5% |
| Distributable reserves | 133 | €44,986 | €50,143 | +€5,158 | +11.5% |
| Amounts payable | 17/49 | €91,984 | €53,568 | -€38,416 | -41.8% |
| Amounts payable after more than one year | 17 | €46,265 | €29,386 | -€16,878 | -36.5% |
| Other amounts payable | 178/9 | €46,265 | €29,386 | -€16,878 | -36.5% |
| Amounts payable within one year | 42/48 | €45,720 | €24,182 | -€21,538 | -47.1% |
| Trade debts | 44 | €35,137 | €22,649 | -€12,488 | -35.5% |
| Suppliers | 440/4 | €35,137 | €22,649 | -€12,488 | -35.5% |
| Taxes, remuneration and social security | 45 | €10,583 | €1,533 | -€9,050 | -85.5% |
| Taxes | 450/3 | €10,583 | €1,533 | -€9,050 | -85.5% |
| Other operating charges | 640/8 | €563 | €577 | +€14 | +2.5% |
| Gross operating margin | 9900 | €45,607 | €6,090 | -€39,517 | -86.6% |
| Operating profit (loss) | 9901 | €45,044 | €5,513 | -€39,531 | -87.8% |
| Financial income | 75/76B | €4,078 | €2,322 | -€1,756 | -43.1% |
| Recurring financial income | 75 | €4,078 | €2,322 | -€1,756 | -43.1% |
| Financial charges | 65/66B | €810 | €591 | -€218 | -27.0% |
| Recurring financial charges | 65 | €810 | €591 | -€218 | -27.0% |
| Profit (loss) for the period before taxes | 9903 | €48,312 | €7,243 | -€41,069 | -85.0% |
| Income taxes | 67/77 | €10,583 | €2,086 | -€8,497 | -80.3% |
| Profit (loss) for the period | 9904 | €37,729 | €5,158 | -€32,572 | -86.3% |
| Profit (loss) for the period to be appropriated | 9905 | €37,729 | €5,158 | -€32,572 | -86.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.